Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950103-18-008673
Filing Date
2018-07-19
Accepted
2018-07-19 16:17:18
Documents
11

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 dp93545_424b5.htm 424B5 768143
2 GRAPHIC image_001.jpg GRAPHIC 2832
3 GRAPHIC image_003.jpg GRAPHIC 1862
4 GRAPHIC image_004.jpg GRAPHIC 1345
5 GRAPHIC image_005.jpg GRAPHIC 1481
6 GRAPHIC image_006.jpg GRAPHIC 1128
7 GRAPHIC image_007.jpg GRAPHIC 1361
8 GRAPHIC image_009.jpg GRAPHIC 2361
9 GRAPHIC image_010.jpg GRAPHIC 2833
10 GRAPHIC image_011.jpg GRAPHIC 43852
11 GRAPHIC image_012.jpg GRAPHIC 1467
  Complete submission text file 0000950103-18-008673.txt   853840
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-224694 | Film No.: 18960633
SIC: 2834 Pharmaceutical Preparations